Related Experiment Video
Updated: Oct 15, 2025

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Targeting the Mycobacterium tuberculosis Stringent Response as a Strategy for Shortening Tuberculosis Treatment
Carina Danchik1, Siqing Wang1, Petros C Karakousis1
1Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, United States.
Abstract:
The stringent response is well conserved across bacterial species and is a key pathway involved both in bacterial survival and virulence and in the induction of antibiotic tolerance in Mycobacteria. It is mediated by the alarmone (p)ppGpp and the regulatory molecule inorganic polyphosphate in response to stress conditions such as nutrient starvation. Efforts to pharmacologically target various components of the stringent response have shown promise in modulating mycobacterial virulence and antibiotic tolerance. In this review, we summarize the current understanding of the stringent response and its role in virulence and tolerance in Mycobacteria, including evidence that targeting this pathway could have therapeutic benefit.
Insights
The bacterial stringent response, mediated by (p)ppGpp alarmones, is crucial for survival and antibiotic tolerance in Mycobacteria. Targeting this pathway shows therapeutic potential for treating mycobacterial infections.
Area of Science:
- Microbiology
- Molecular Biology
- Drug Discovery
Background:
- The stringent response is a conserved bacterial pathway vital for survival under stress.
- This response involves alarmones like guanosine tetraphosphate/guanosine pentaphosphate ((p)ppGpp) and inorganic polyphosphate.
- In Mycobacteria, it significantly influences virulence and antibiotic tolerance.
Purpose of the Study:
- To review the current understanding of the stringent response in Mycobacteria.
- To elucidate the role of the stringent response in mycobacterial virulence and antibiotic tolerance.
- To explore the therapeutic potential of targeting this pathway.
Main Methods:
- Literature review of existing research on the stringent response.
- Analysis of studies investigating (p)ppGpp and inorganic polyphosphate roles.
- Examination of evidence for therapeutic interventions targeting the stringent response.
Main Results:
- The stringent response is essential for Mycobacteria survival and adaptation to stress.
- (p)ppGpp and inorganic polyphosphate are key mediators of this response.
- Pharmacological targeting of the stringent response pathway demonstrates promise.
Conclusions:
- The stringent response is a critical factor in mycobacterial pathogenesis and drug resistance.
- Modulating the stringent response could offer novel therapeutic strategies against Mycobacteria.
- Further research into targeting this pathway may yield significant clinical benefits.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Stringent Response in E. coli

